Credit Suisse’s SteadyMed Ltd STDY Stock Holding History

Credit Suisse’s Portfolio STDY Stock Details STDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-710,098	Closed	-$3.19M	–	4136
2018 Q2	$3.19M	Buy	+710,098	New	+$2.9M	﹤0.01%	2074

Other funds holding STDY

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return

HCMT

Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Credit Suisse's STDY Position: Q3 2018 in Review

Credit Suisse sold out of SteadyMed Ltd (STDY) in Q3 2018, closing a stake of 710,098 shares — an estimated $3.19M sold.

Credit Suisse first reported a position in STDY in Q2 2018 and held it in 1 quarter. The position peaked at $3.19M in Q2 2018. 5 funds tracked by Wall St. Rank hold STDY as of Q3 2018.

Credit Suisse reported no remaining SteadyMed Ltd position as of Q3 2018 after selling out during the quarter.
Credit Suisse sold 710,098 SteadyMed Ltd shares in Q3 2018, an estimated $3.19M.
Credit Suisse first reported a position in SteadyMed Ltd in Q2 2018 and held it in 1 quarter.
Credit Suisse's SteadyMed Ltd position peaked at $3.19M in Q2 2018.
5 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2018.

Based on Credit Suisse's 13F filing for Q3 2018, filed 13 Nov 2018.